You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 160 No. 15, August 14, 2000 TABLE OF CONTENTS
  Archives
  •  Online Features
  Review Article
 This Article
 •Full text
 •PDF
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Citing articles on Web of Science (36)
 •Contact me when this article is cited
 Related Content
 •Related article
 •Similar articles in this journal
 Topic Collections
 •Women's Health
 •Menopause
 •Review
 •Alert me on articles by topic
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati Add to Twitter What's this?

The Role of Hormone Replacement Therapy in the Prevention of Postmenopausal Heart Disease

Lori Mosca, MD, PhD

Arch Intern Med. 2000;160:2263-2272.

Coronary heart disease is the single leading cause of death in women and a significant cause of disability. Menopause adversely affects several risk factors for coronary heart disease, suggesting that hormones influence the risk of coronary heart disease in postmenopausal women. This article reviews the observational and clinical trial data evaluating the relation between cardiovascular disease and hormone replacement therapy. Biological mechanisms of estrogen and the impact of adding progestins are emphasized. Potential risks and benefits of therapy are discussed. The relative effects of other estrogen and lipid-lowering therapies for preventing coronary heart disease in postmenopausal women are highlighted.


From the New York-Presbyterian Hospital of Columbia and Cornell Universities, New York, NY.



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?

RELATED ARTICLE

Archives of Internal Medicine Reader's Choice: Continuing Medical Education
Arch Intern Med. 2000;160(15):2404.
FULL TEXT  


THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Low-dose estrogen therapy does not change postexercise hypotension, sympathetic nerve activity reduction, and vasodilation in healthy postmenopausal women
Oneda et al.
Am. J. Physiol. Heart Circ. Physiol. 2008;295:H1802-H1808.
ABSTRACT | FULL TEXT  

Hormone Replacement Therapy and the Cardiovascular System: Lessons Learned and Unanswered Questions
Ouyang et al.
J Am Coll Cardiol 2006;47:1741-1753.
ABSTRACT | FULL TEXT  

Reproductive History in Women with Lower Limb Ischemia
Hultgren et al.
ANGIOLOGY 2004;55:373-383.
ABSTRACT  

Hormone Replacement Therapy and Its Relationship to Lipid and Glucose Metabolism in Diabetic and Nondiabetic Postmenopausal Women: Results from the Third National Health and Nutrition Examination Survey (NHANES III)
Crespo et al.
Diabetes Care 2002;25:1675-1680.
ABSTRACT | FULL TEXT  

Overview of gender aspects of cardiac syndrome X
Kaski
Cardiovasc Res 2002;53:620-626.
ABSTRACT | FULL TEXT  

Hormone Replacement Therapy and Cardiovascular Disease: A Statement for Healthcare Professionals From the American Heart Association
Mosca et al.
Circulation 2001;104:499-503.
FULL TEXT  

Observational Data Do Not Establish Cause and Effect
Watts
Arch Intern Med 2001;161:772-772.
FULL TEXT  

The Role of HRT in Cardiovascular Disease
Rozenberg et al.
Arch Intern Med 2001;161:773-773.
FULL TEXT  





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 2000 American Medical Association. All Rights Reserved.